TABARRINI, Oriana
 Distribuzione geografica
Continente #
AS - Asia 7.447
NA - Nord America 7.052
EU - Europa 5.178
SA - Sud America 742
AF - Africa 126
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 20.555
Nazione #
US - Stati Uniti d'America 6.908
CN - Cina 2.899
SG - Singapore 2.258
IT - Italia 965
VN - Vietnam 793
IE - Irlanda 769
UA - Ucraina 699
RU - Federazione Russa 668
HK - Hong Kong 650
SE - Svezia 595
BR - Brasile 577
DE - Germania 351
FI - Finlandia 246
FR - Francia 234
GB - Regno Unito 179
KR - Corea 178
IN - India 116
BE - Belgio 106
BD - Bangladesh 89
TR - Turchia 88
PL - Polonia 83
CA - Canada 66
AR - Argentina 59
JP - Giappone 56
MX - Messico 55
IQ - Iraq 52
AT - Austria 51
RO - Romania 45
NL - Olanda 44
PK - Pakistan 39
UZ - Uzbekistan 36
ES - Italia 34
SA - Arabia Saudita 34
ID - Indonesia 29
ZA - Sudafrica 29
CH - Svizzera 28
EC - Ecuador 25
CZ - Repubblica Ceca 23
PH - Filippine 20
VE - Venezuela 18
CI - Costa d'Avorio 17
CO - Colombia 17
CL - Cile 16
EG - Egitto 15
AE - Emirati Arabi Uniti 13
MA - Marocco 13
ET - Etiopia 12
KE - Kenya 12
PY - Paraguay 12
JO - Giordania 11
LB - Libano 10
MY - Malesia 10
GR - Grecia 8
IL - Israele 8
IR - Iran 8
LT - Lituania 8
LV - Lettonia 8
TN - Tunisia 8
UY - Uruguay 7
PA - Panama 6
PE - Perù 6
KG - Kirghizistan 5
NP - Nepal 5
AL - Albania 4
AO - Angola 4
BG - Bulgaria 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EU - Europa 4
KZ - Kazakistan 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
AU - Australia 3
AZ - Azerbaigian 3
BH - Bahrain 3
HR - Croazia 3
JM - Giamaica 3
LK - Sri Lanka 3
LY - Libia 3
NI - Nicaragua 3
OM - Oman 3
RS - Serbia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NO - Norvegia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TM - Turkmenistan 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 20.533
Città #
Guangzhou 2.083
Singapore 1.662
Chandler 1.002
Dublin 769
San Jose 668
Hong Kong 634
Perugia 536
Dong Ket 503
San Mateo 414
Ashburn 405
Jacksonville 358
Boardman 278
Santa Clara 262
Beijing 202
Moscow 185
Medford 177
Princeton 176
Seoul 174
Lauterbourg 162
Ann Arbor 146
Wilmington 134
Los Angeles 131
Altamura 125
The Dalles 117
Lawrence 111
Ho Chi Minh City 110
Brussels 106
Munich 104
New York 98
Andover 95
Piscataway 76
Fremont 67
São Paulo 65
Hanoi 61
West Jordan 58
Warsaw 53
Tokyo 51
Des Moines 50
Orem 48
Helsinki 47
Saint Petersburg 47
Turku 46
Redmond 43
Dallas 42
Nanjing 40
Vienna 35
Atlanta 34
Norwalk 34
Brooklyn 33
Council Bluffs 32
Woodbridge 31
Izmir 30
Chennai 28
Chicago 28
Denver 27
Bucharest 26
Baghdad 25
Hefei 25
Montreal 25
Dhaka 24
Rome 24
Buffalo 23
Rio de Janeiro 22
San Paolo di Civitate 21
Dearborn 20
Phoenix 20
Shanghai 20
Tashkent 20
Ankara 19
Houston 19
London 19
Mexico City 19
Poplar 19
Redwood City 19
Stockholm 19
Falls Church 18
Johannesburg 18
Abidjan 17
Columbus 17
Da Nang 17
Spoleto 16
San Diego 15
Secaucus 15
Nuremberg 14
Philadelphia 14
Porto Alegre 14
Seattle 14
Toronto 14
Barnet 13
Chongqing 13
Lahore 13
Mumbai 13
Riyadh 13
Belo Horizonte 12
Haiphong 12
Hanover 12
Manchester 12
Milan 12
Addis Ababa 11
Amsterdam 11
Totale 13.811
Nome #
Structural investigation of Small Molecules Targeting Influenza A Virus Polymerase 2.140
1,4-Benzothiazine-2-carboxylic Acids 1-Oxide as Analogue of Antibacterial Quinolones 339
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 333
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 320
(1,4-Benzothiazinyloxy)alkylpiperazine Derivatives as Potential Antihypertensive Agents 315
6-Aminoquinolones, their Synthesis and their Use as Antibacterial Agents. 251
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 204
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 182
4H-1,4-Benzothiopyran-4-one-3-carboxylic Acids and 3,4-Dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as Quinolone Antibacterial Analogs 162
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 155
A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity 155
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 153
[1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes 146
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 145
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 143
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 143
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 142
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 141
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 140
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 139
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 138
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 137
Chemometric Rationalization of the Structural and Physicochemical Basis for Selective Cyclooxygenase-2 Inhibition: Toward More Specific Ligands 134
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 134
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors 134
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 134
2-phenylquinolones as HIV-1 Tat/TAR interaction inhibitors 133
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 133
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 132
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 128
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 127
6-Aminoquinolones as New Potential Anti-HIV Agents 126
6-Desfluoroquinolones as promising HIV transcription inhibitors 126
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 126
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 126
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 124
7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-COa reductase inhibitors 124
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 123
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 123
S. aureus NorA efflux pump: the discovery of new potent inhibitors 122
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10 122
6-Aminoquinolones: photostability, cellular distribution and phototoxicity. 120
N-Benzoyl-N-methylsulfonyl anthranilates: unexpected cyclization reaction to 4-alkoxy-2,1-benzothiazines 120
Acting on Tat-Mediated Transcription to Achieve a Long Term Control of HIV-1 Latency 117
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 117
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 116
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 116
Cell-dependent Interference with viral transactivation by 6-aminoquinolone derivatives. 115
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 115
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 113
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 113
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 112
Disegno di nuovi chinoloni ad attività antitubercolare: dalla 3D-QSAR agli algoritmi evolutivi. 112
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 112
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 112
A New Derivative with Ultra-Potent Anti-HIV Activity 110
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 110
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 110
6-Hydroxy Derivative as New Desfluoroquinolone (DFQ): Synthesis and DNA-binding Study 109
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 109
A new 6-aminoquinolone compound with anti-HCMV activity 108
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 108
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 107
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 106
Antiviral Activity of WC5, a new 6-aminoquinolone compound against Human Herpesviruses 106
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 105
CYCLOHEPTATHIOPHENE-3-CARBOXAMIDE DERIVATIVES AS INFLUENZA A VIRUS POLYMERASE INHIBITORS 105
Derivati 1,4-benzotiazinici come agenti anticonvulsivanti. 104
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 104
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 104
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 103
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 103
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 103
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 102
A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors. 101
QSAR study and VolSurf characterization of anti-HIV quinolone library 101
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 101
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 101
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 100
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 100
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 100
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 99
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 98
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 97
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 97
Antiviral 6-aminoquinolones: Molecolar basis for potency and selectivity. 96
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 96
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 95
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 95
Quinolones as potential anti HIV-1 agents targeted at Tat/TAR recognition 94
Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs 94
In Vitro Activities of New Quinolones Against Helicobacter pylori 93
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 92
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 91
New compounds targeting the rna polymerase of influenza a and b viruses. 90
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 89
Nuovi Tiopiranopiridinil Chinoloni 89
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 89
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 89
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15 88
Totale 14.655
Categoria #
all - tutte 81.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021532 0 0 0 0 0 0 0 0 0 0 0 532
2021/20221.733 52 301 36 112 116 11 32 488 89 51 211 234
2022/20232.873 199 482 37 268 266 304 3 171 1.001 21 87 34
2023/20243.324 69 191 67 30 20 29 2.333 28 137 88 148 184
2024/20253.157 35 270 115 261 367 163 292 182 544 196 483 249
2025/20266.400 426 446 322 834 835 596 1.054 366 708 520 235 58
Totale 21.106